RxDoctor Payments Data

Grace Ma, MD

Plastic and Reconstructive Surgery · Atlanta, GANPI 1992707335

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $14,956 of the $16,622 with a category attached, or 90.0%. 24 manufacturers reported payments, led by Mentor Worldwide LLC at 33.2% of the total.

$16,622in general payments, 2019–2025

Across 476 payments — averaging $34.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mentor Worldwide LLC$6K
  • AbbVie$5K
  • Axogen$2K
  • RTI Surgical, Inc$1K
  • Musculoskeletal Transplant Foundation Inc.$1K
  • Bard Peripheral Vascular, Inc.$839
  • plus $1K from 18 others

What the payments were for

  • Speaking & faculty fees$1,2007%
  • Travel & lodging$4653%
  • Food & beverage$14,95690%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,622 in reported general payments places this provider in the 80th percentile of 83 plastic and reconstructive surgery providers in Georgia.

See all plastic and reconstructive surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$26,821
Medicare patients
51
Services billed
114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Monohydrate14$201
Ondansetron OdtOndansetron13$125
Cefadroxil11$74
Tramadol Hcl12$28

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →